Shares of Kodiak Sciences surged sharply on Thursday after the biotechnology company reported positive results from a ...

Wave Life Sciences stock crashed Thursday after the company's much-hyped "body composition" drug led to just 1% weight loss in six months.

March 26 (Reuters) - Shares of drug developer Kodiak Sciences jumped 52% before the bell on Thursday after its experimental drug met the main goal in a late-stage study in patients with ...

Shares of Kodiak Sciences shot higher after the company disclosed what it called positive results from a late-stage study of its treatment for diabetic retinopathy, a progressive disease that occurs ...

Anavex Life Sciences (AVXL) stock crashed on March 25 after the company unexpectedly withdrew its marketing authorization ...

Wave Life Sciences shares plunged over 55% on Thursday after a higher dose of its experimental ​obesity drug failed to show a ...

Stewart reaffirmed the company's near-term priority as "receiving NDA approval and successfully launching cytisinicline for smoking cessation," with a planned commercial launch in the first half of ...

Achieve exceeded long-term safety study requirements and secured a manufacturing partnership, positioning for a potential 1H ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...